CIK 0001357874
- Non-accelerated filer
- Smaller reporting company
PRECISION BIOSCIENCES INC
Sign in to watch- Ticker
- DTIL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- May 21
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 919-314-5512
- Business address
- 302 EAST PETTIGREW STREET, SUITE A-100, DURHAM, NC, 27701
- 4 Open-market sale Chief Medical Officer sold 7,775 shares at $2.10 ($16,328)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Financial Officer bought 16,677 shares at $3.08 ($51,365)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award VP & Corporate Controller acquired 2,659 shares (grant or award)
- 4 Grant or award General Counsel and Secretary acquired 10,573 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 3,712 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Operating Officer sold 30,000 shares at $10.65 ($319,500)
- 4 Open-market sale Chief Operating Officer sold 15,000 shares at $10.77 ($161,550)
- 4 Open-market sale Chief Operating Officer sold 20,000 shares at an average $10.72 ($214,400)
- 4 Open-market sale Chief Operating Officer sold 2,858 shares at $11.20 ($32,010)
- 4 Open-market sale Chief Operating Officer sold 30,000 shares at $11.52 ($345,600)
Page 9 of 14 · 269 filings